Invention Grant
- Patent Title: Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapy
-
Application No.: US17100223Application Date: 2020-11-20
-
Publication No.: US11304978B2Publication Date: 2022-04-19
- Inventor: Barbara Sennino , Kyle Jacoby , Stefanie Mandl-Cashman , Michael M. Dubreuil , John Gagnon , Alex Franzusoff
- Applicant: PACT PHARMA, INC.
- Applicant Address: US CA South San Francisco
- Assignee: PACT PHARMA, INC.
- Current Assignee: PACT PHARMA, INC.
- Current Assignee Address: US CA South San Francisco
- Agency: Baker Botts L.L.P.
- Main IPC: C07K14/705
- IPC: C07K14/705 ; A61K35/17 ; C07K14/725 ; C12N5/0783 ; C12N9/22 ; C12N15/113
Abstract:
Compositions comprising and methods for the treatment of cancer using a neoTCR based cell therapy with a CD8 expression construct.
Public/Granted literature
- US20210085721A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER USING A CD8 ENGINEERED T CELL THERAPY Public/Granted day:2021-03-25
Information query
